Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

[Analysis of serum neutralizing antibody response in patients with primary dengue virus type 1 infection].

Hu D, Li J, Wang D, DI B, Qiu L, Wang Y, Ding X, Che X.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Dec;32(12):1773-6, 1791. Chinese.

PMID:
23268408
[PubMed - indexed for MEDLINE]
Free Article
2.

Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.

Lai CY, Williams KL, Wu YC, Knight S, Balmaseda A, Harris E, Wang WK.

PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2451. doi: 10.1371/journal.pntd.0002451. eCollection 2013.

PMID:
24069496
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.

Ito M, Katakai Y, Ono F, Akari H, Mukai RZ, Takasaki T, Kotaki A, Kurane I.

Arch Virol. 2011 Jun;156(6):1073-7. doi: 10.1007/s00705-011-0959-2. Epub 2011 Mar 16.

PMID:
21409446
[PubMed - indexed for MEDLINE]
4.

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.

de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1188. doi: 10.1371/journal.pntd.0001188. Epub 2011 Jun 21. Erratum in: PLoS Negl Trop Dis. 2011 Aug;5(8). doi: 10.1371/annotation/f585335f-ff77-40ae-a8b6-ad6019af31aa. Brian, James [corrected to Brien, James D].

PMID:
21713020
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Neutralizing antibodies after infection with dengue 1 virus.

Guzman MG, Alvarez M, Rodriguez-Roche R, Bernardo L, Montes T, Vazquez S, Morier L, Alvarez A, Gould EA, Kouri G, Halstead SB.

Emerg Infect Dis. 2007 Feb;13(2):282-6.

PMID:
17479892
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.

Puschnik A, Lau L, Cromwell EA, Balmaseda A, Zompi S, Harris E.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2274. doi: 10.1371/journal.pntd.0002274. Print 2013.

PMID:
23785536
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.

Zompi S, Montoya M, Pohl MO, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2012;6(3):e1568. doi: 10.1371/journal.pntd.0001568. Epub 2012 Mar 20.

PMID:
22448292
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.

van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, Nisalak A, Burke DS, Cummings DA.

J Infect Dis. 2010 Oct 1;202(7):1002-10. doi: 10.1086/656141.

PMID:
20738205
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.

Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I.

PLoS Negl Trop Dis. 2012;6(2):e1536. doi: 10.1371/journal.pntd.0001536. Epub 2012 Feb 28.

PMID:
22389741
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.

Tsai WY, Lai CY, Wu YC, Lin HE, Edwards C, Jumnainsong A, Kliks S, Halstead S, Mongkolsapaya J, Screaton GR, Wang WK.

J Virol. 2013 Dec;87(23):12562-75. doi: 10.1128/JVI.00871-13. Epub 2013 Sep 11.

PMID:
24027331
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells.

Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I.

Clin Vaccine Immunol. 2010 Mar;17(3):402-7. doi: 10.1128/CVI.00396-09. Epub 2009 Dec 30.

PMID:
20042518
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.

Ito M, Mukai RZ, Takasaki T, Kotaki A, Kurane I.

Arch Virol. 2010 Oct;155(10):1617-24. doi: 10.1007/s00705-010-0741-x. Epub 2010 Jul 20.

PMID:
20644969
[PubMed - indexed for MEDLINE]
13.

Neutralizing antibody response variation against dengue 3 strains.

Alvarez M, Pavon-Oro A, Rodriguez-Roche R, Bernardo L, Morier L, Sanchez L, Alvarez AM, Guzmán MG.

J Med Virol. 2008 Oct;80(10):1783-9. doi: 10.1002/jmv.21234.

PMID:
18712848
[PubMed - indexed for MEDLINE]
14.

[Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico].

Sánchez-Burgos GG, López-Alvarado MA, Castañeda-Desales D, Ruiz-Gómez J, Ramos-Castañeda J.

Salud Publica Mex. 2008 Sep-Oct;50(5):362-6. Spanish.

PMID:
18852932
[PubMed - indexed for MEDLINE]
Free Article
15.

Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA.

Emmerich P, Mika A, Schmitz H.

PLoS Negl Trop Dis. 2013 Dec 26;7(12):e2580. doi: 10.1371/journal.pntd.0002580. eCollection 2013.

PMID:
24386498
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.

Chang SF, Huang JH, Chen LK, Su CL, Liao TL, Chien LJ, Lin TH, Su CJ, Shu PY.

J Microbiol Immunol Infect. 2008 Oct;41(5):377-85.

PMID:
19122918
[PubMed - indexed for MEDLINE]
17.

Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.

Moi ML, Takasaki T, Saijo M, Kurane I.

Trans R Soc Trop Med Hyg. 2013 Jan;107(1):51-8. doi: 10.1093/trstmh/trs007.

PMID:
23296697
[PubMed - indexed for MEDLINE]
18.

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, Rey FA, Varani L, Whitehead SS, Diamond MS, Harris E, Lanzavecchia A, Sallusto F.

Cell Host Microbe. 2010 Sep 16;8(3):271-83. doi: 10.1016/j.chom.2010.08.007.

PMID:
20833378
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[To evaluate the neutralizing abilities of anti-dengue virus antibodies with nonstructural protein 1 antigen capture enzyme-linked immunosorbent assay].

Wen K, Ding YQ, Qiu LW, Pan YX, Cai JP, Yue CF, DI B, Che XY.

Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Aug;43(8):680-5. Chinese.

PMID:
20021846
[PubMed - indexed for MEDLINE]
20.

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.

Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE Jr.

MBio. 2013 Nov 19;4(6):e00873-13. doi: 10.1128/mBio.00873-13.

PMID:
24255124
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk